|Previous Section||Index||Home Page|
Ms Blears: The number of residential and nursing care establishment closures in 1999 and 2000, together with the number of new registrations, are presented in the table. Information is not available centrally on the number of beds associated with closures or new registrations.
|Number of establishment closures|
|Number of new registrations|
(55) Information presented for West Sussex county council.
(56) Information presented for West Sussex health authorities.
Registration and Inspection Survey
10 Dec 2001 : Column: 719W
Mr. Flight: To ask the Secretary of State for Health in each quarter in (a) 2000 and (b) 2001, how many hospital beds were unavailable in Arundel and South Downs to incoming patients as a result of their occupation by (i) delayed discharge patients who were awaiting social services funding and (ii) delayed discharge patients who had fully funded social services packages arranged. 
Mr. Flight: To ask the Secretary of State for Health how many operations have been cancelled in Arundel and South Downs, in each quarter in (a) 2000 and (b) 2001, as a result of hospital beds being occupied by (i) delayed discharge patients who are awaiting social services funding or assessment and (ii) delayed discharge patients who had fully funded social services packages arranged. 
Statistics on the number of operations cancelled for non-medical reasons in each health authority are collected on a quarterly basis. Copies are available in the Library. The latest figures are for quarter 1 (April-June) of the 200102 financial year.
Mr. Goodman: To ask the Secretary of State for Health when he will assess the effectiveness of the neonatal screening programme for haemoglobinopathies to be introduced next year; and what criteria he will use. 
Jacqui Smith: The NHS plan sets out our commitment to introduce by 2004 a new and effective screening programme for women and children including a new national linked antenatal and neonatal programme for haemoglobinopathies.
Mr. Goodman: To ask the Secretary of State for Health how many bone marrow transplants were carried out in the United Kingdom during the past five years in relation to (a) sickle cell, (b) thalassaemia and (c) other haemoglobinopathies; and with what success rate. 
10 Dec 2001 : Column: 720W
Jacqui Smith: The latest figures at April 2001 show that 99 transplants for haemoglobinopathy have been reported to the United Kingdom Children's Bone Marrow Transplant Registry since 1993. 17 children have received transplants for sickle cell disease, 16 are alive (94 per cent.) and 15 (88 per cent.) are cured. 77 children with thalassaemia have been transplanted and have undergone 82 procedures. 69 are alive (90 per cent. ) and 62 (81 per cent.) are cured.
Mr. Goodman: To ask the Secretary of State for Health what plans the Standing Medical Advisory Committee has to issue a further report on sickle cell, thalassaemia and other haemoglobinopathies. 
Mr. Goodman: To ask the Secretary of State for Health what Government expenditure on directly commissioned research into (a) sickle cell, (b) thalassaemia and (c) other haemoglobinopathies was in (i) 1999 and (ii) 2000. 
Jacqui Smith: The main Government agency for research into the causes of and treatments for disease is the Medical Research Council (MRC), which receives its funding via the Department of Trade and Industry. In 19992000, the MRC expenditure on all haemoglobinopathies was £815,000. In 200001, the MRC expenditure was £823,000.
The Department funds research to support policy development and the delivery of effective practice in the national health service. Research programme and project details can be found on relevant websites, especially that of the National Research Register (NRR), all of which can be accessed through www.doh.gov.uk/research.
The Department core funds the Centre for Reviews and Dissemination and 22 Cochrane Review Groups, one of which, on cystic fibrosis and genetic disorders, covers this area. Details of reviews can be found on the National Research Register and outputs can be found on the research findings register and/or the Cochrane Database.
The financial information requested for Department of Health funded projects could be provided only at disproportionate cost. Management of much of the research supported by NHS research and development programmes is devolved. Expenditure at project level is not held centrally at this level of detail.
Mr. Hutton: Our proposals for the new consultant contract, published in February, envisage that for an initial period, perhaps seven years, the terms of the contract would prevent those newly appointed consultants engaging in similar work outside the national health service.
10 Dec 2001 : Column: 721W
Matthew Green: To ask the Secretary of State for Health what assessment he has made of the viability of a West Mercia Strategic Health Authority based on Shropshire, Herefordshire and Worcestershire. 
In considering the responses to consultation, Ministers will take account of views for and against the original options proposed, as well as other alternatives proposed during the consultation process.
Mr. Burstow: To ask the Secretary of State for Health if he will estimate the total unallocated funds within his departmental expenditure limit (a) at the start of the financial year and (b) to date; and what was the month seven forecast on outturn underspend against his departmental expenditure limit in (i) real and (ii) percentage terms. 
Mr. Hutton: The Department's Departmental Annual Report for 200102 contains the departmental unallocated provision (DUP), set for the present financial year in Annex A3 (current) and annex A4 (capital). Draw down of part of this DUP has been reported to Parliament at winter supplementary estimates.
10 Dec 2001 : Column: 722W
|Next Section||Index||Home Page|